Related references
Note: Only part of the references are listed.Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Should intravenous iron be the standard of care in oncology?
Michael Auerbach
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Laurent Bastit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa
Paolo Pedrazzoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
David H. Henry et al.
ONCOLOGIST (2007)
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
JL Babitt et al.
NATURE GENETICS (2006)
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
M Auerbach et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
E Nemeth et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Hepcidin, a new iron regulatory peptide
G Nicolas et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy
J Crawford et al.
CANCER (2002)
Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect
HA Papadaki et al.
BLOOD (2002)
Share Paper
